Takeda Pharmaceutical Co Ltd
TAK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395064
In the last 90 days, Takeda Pharmaceutical Co Ltd insiders filed 0 open-market purchases and 6 sales; 382 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; no superinvestor holds it.
Other share classesTKPHF
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $5.52M in total
- 6
- 13F holdersQ2 2026, +25 vs. previous quarter
- 382
- 13F valueReported value at the end of Q2 2026
- $1.67B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in JPY.
- Revenue, FY2025
- JPY 4.58T
- +7.5% year over year
- Net income, FY2025
- JPY 108.1B
- −25.0% year over year
- Free cash flow, FY2025
- JPY 856.4B
- +58.3% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 3.07M
- Shares sold short
- Change
- −222.7K
- −6.8% vs. previous
- Days to cover
- 1.02
- At average daily volume
Superinvestors holding TAK, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding TAK at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Takeda Pharmaceutical Co Ltd insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 (view filing)3:54 PM ET | Nov 4 | 1 day | Platford Giles RichardPresident, IBU | SSaleAmerican Depositary Shares | −55.6K | $20.90 | −$1.16M | −17.1%270.3K after | |
| Nov 4, 2026 (view filing)5:35 PM ET | Nov 2 | 2 days | Bitetti Teresa MariePresident, OBU | SSaleAmerican Depositary Shares | −46.6K | $20.89 | −$973.7K | −17.9%214.5K after | |
| Sep 15, 2026 (view filing)9:12 PM ET | Sep 14 | 1 day | Duprey Lauren RusckowskiChief Transformation Officer | SSaleAmerican Depositary Shares | −34.5K | $18.54 | −$640.3K | −15.3%191.5K after | |
| Sep 3, 2026 (view filing)9:49 PM ET | Sep 2 | 1 day | Plump Andrew StewartPresident, R&D | SSaleAmerican Depositary Shares | −116.2K | $18.49 | −$2.15M | −44.4%145.5K after | 10b5-1 |
| Aug 21, 2026 (view filing)4:30 PM ET | Aug 19 | 2 days | Plump Andrew StewartPresident, R&D | SSaleAmerican Depositary Shares | −19.7K | $18.49 | −$363.3K | −7.0%261.7K after | 10b5-1 |
| Aug 19, 2026 (view filing)4:15 PM ET | Aug 18 | 1 day | Greenway Nicola Deidre PetalChief Human Resources Officer | SSaleAmerican Depositary Shares | −13.0K | $18.11 | −$235.1K | −24.5%40.0K after | |
| Aug 12, 2026 (view filing)9:54 PM ET | Aug 10 | 2 days | Farajallah Awny Samaan BotrosChief Medical Officer | SSaleAmerican Depositary Shares | −14.0K | $17.10 | −$239.5K | −10.8%116.2K after | |
| Aug 12, 2026 (view filing)9:53 PM ET | Aug 10 | 2 days | Ibrahim Ramy Riad AhmedPresident, PDT BU | SSaleAmerican Depositary Shares | −7.28K | $17.10 | −$124.4K | −6.6%102.6K after | |
| Aug 12, 2026 (view filing)9:53 PM ET | Aug 10 | 2 days | Pacheco Rhonda JanicePresident, U.S. Business Unit | SSaleAmerican Depositary Shares | −16.9K | $17.10 | −$289.0K | −8.5%182.5K after | |
| Aug 12, 2026 (view filing)9:51 PM ET | Aug 10 | 2 days | Duprey Lauren RusckowskiChief Transformation Officer | SSaleAmerican Depositary Shares | −47.6K | $17.10 | −$813.7K | −17.4%226.1K after |
Top 10 13F holders, Q2 2026
See all 382 holdersThe largest institutional positions in Takeda Pharmaceutical Co Ltd at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Capital Research Global Investors | 19,297,680 | $309.3M | 0.04% | +193,461+1.0% | Added |
| FMR LLC | 9,599,302 | $153.9M | 0.01% | +2,481,816+34.9% | Added |
| Morgan Stanley | 6,994,924 | $112.1M | 0.01% | +525,324+8.1% | Added |
| Adage Capital Partners GP, L.L.C. | 6,050,771 | $97.0M | 0.14% | −374,213−5.8% | Reduced |
| Goldman Sachs Group Inc | 5,125,032 | $82.2M | 0.01% | −493,696−8.8% | Reduced |
| Brandes Investment Partners, LP | 4,539,347 | $72.8M | 0.51% | +108,705+2.5% | Added |
| Arrowstreet Capital, Limited Partnership | 3,732,924 | $59.8M | 0.03% | +616,613+19.8% | Added |
| BlackRock, Inc. | 3,688,166 | $59.1M | 0.00% | +511,745+16.1% | Added |
| Renaissance Technologies LLC | 2,568,000 | $41.2M | 0.06% | −421,100−14.1% | Reduced |
| Qube Research & Technologies Ltd | 2,207,432 | $35.4M | 0.04% | +2,207,432 | New |
Politician trades
All politician trades in TAK3 members of Congress reported 6 trades in Takeda Pharmaceutical Co Ltd since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $1K-$15K |
| Sep 5, 2023 |  Virginia Foxx House · NC | Sell | $15K-$50K |
| Aug 13, 2023 |  Daniel S. Goldman House · NY | Sell | $15K-$50K |
| Mar 20, 2023 | Daniel S. Goldman House · NY | Buy | $1K-$15K |
| Mar 3, 2023 | Virginia Foxx House · NC | Buy | $1K-$15K |
Senate · OK · Jul 21, 2026
Buy$1K-$15K
House · NC · Sep 5, 2023
Sell$15K-$50K
House · NY · Aug 13, 2023
Sell$15K-$50K
House · NY · Mar 20, 2023
Buy$1K-$15K
House · NC · Mar 3, 2023
Buy$1K-$15K